Pan‐Immune‐Inflammation Value for Mortality Risk Stratification in Critically Ill Patients With Acute Ischemic Stroke: A Cohort Study Based on the MIMIC ‐ IV Database | Synapse
March 15, 2026Open Access
Pan‐Immune‐Inflammation Value for Mortality Risk Stratification in Critically Ill Patients With Acute Ischemic Stroke: A Cohort Study Based on the MIMIC ‐ IV Database
Key Points
This research aims to explore the relationship between Pan-Immune-Inflammation Value and mortality risk in patients with acute ischemic stroke.
Cohort study design using the MIMIC-IV database
Analysis of the relationship between PIV and mortality risks in critically ill patients
Evaluation of short- and long-term all-cause mortality (ACM) outcomes
PIV showed a reverse L-shaped relationship with short- and long-term ACM
Demonstrated utility of PIV for risk stratification in critically ill acute ischemic stroke patients
Abstract
PIV exhibited a reverse L-shaped relationship with short- and long-term ACM in critical AIS, and served as a tool for ACM risk stratification.